|
Reshape Lifesciences Inc (RSLS) |
|
Reshape Lifesciences Inc
RSLS's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Reshape Lifesciences Inc 's sales fell
by -10.44 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2117
Medical Equipment & Supplies industry recorded
growth of revenues by 2.3 %
Reshape Lifesciences Inc net loss decreased from $-3 millions, to $-2 millions in II. Quarter 2024,
• More on RSLS's Growth
|
|
Reshape Lifesciences Inc realized a net loss in trailing twelve months.
Reshape Lifesciences Inc realized cash reduction of $ -8.08 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.28.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.2.
• More on RSLS's Valuation
|
|
|
|
|
Reshape Lifesciences Inc realized net loss in trailing twelve months.
Reshape Lifesciences Inc realized cash outflow of $ -8.08per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.28.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.2.
Reshape Lifesciences Inc Price to Book Ratio is at 0.73 higher than Industry Avg. of -182.65, and higher than S&P 500 Avg. of 0
• More on RSLS's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com